EBS - Emergent Biosolutions - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

EBS is currently covered by 5 analysts with an average price target of $14.57. This is a potential upside of $10.18 (231.89%) from yesterday's end of day stock price of $4.39.

Emergent Biosolutions's activity chart (see below) currently has 70 price targets and 73 ratings on display. The stock rating distribution of EBS is 85% BUY, 10% HOLD and 5% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 61.3% with an average time for these price targets to be met of 92.33 days.

Highest price target for EBS is $16, Lowest price target is $12, average price target is $14.5.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 01-Apr-2025. First documented stock forecast 27-Sep-2017.

Currently out of the existing stock ratings of EBS, 17 are a BUY (85%), 2 are a HOLD (10%), 1 are a SELL (5%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$15

$10.61 (241.69%)

$15

11 days ago
(01-Apr-2025)

0/6 (0%)

$10.26 (216.46%)

Buy

$12

$7.61 (173.35%)

$8

5 months 5 days ago
(07-Nov-2024)

7/11 (63.64%)

$1 (9.09%)

23

Buy

$16

$11.61 (264.46%)

$23

6 months 30 days ago
(13-Sep-2024)

10/14 (71.43%)

$8.13 (103.30%)

134

Sell

$9

1 years 4 months 23 days ago
(20-Nov-2023)

2/3 (66.67%)

$0.88 (10.84%)

7

Hold

$15

$10.61 (241.69%)

$29

1 years 10 months 24 days ago
(19-May-2023)

4/8 (50%)

$6.83 (83.60%)

86

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is EBS (Emergent Biosolutions) average time for price targets to be met?

On average it took 92.33 days on average for the stock forecasts to be realized with a an average price target met ratio 61.3

Which analyst has the current highest performing score on EBS (Emergent Biosolutions) with a proven track record?

BRANDON FOLKES

Which analyst has the current lower performing score on EBS (Emergent Biosolutions) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the most public recommendations on EBS (Emergent Biosolutions)?

Brandon Folkes works at CIBC and has 4 price targets and 2 ratings on EBS

Which analyst is the currently most bullish on EBS (Emergent Biosolutions)?

Dana Flanders with highest potential upside - $97.6

Which analyst is the currently most reserved on EBS (Emergent Biosolutions)?

David Maris with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?